177 related articles for article (PubMed ID: 35540224)
1. Drug-likeness of linear pentamidine analogues and their impact on the hERG K
Żołek T; Qile M; Kaźmierczak P; Bloothooft M; van der Heyden MAG; Maciejewska D
RSC Adv; 2019 Nov; 9(66):38355-38371. PubMed ID: 35540224
[TBL] [Abstract][Full Text] [Related]
2. A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity.
Anwar-Mohamed A; Barakat KH; Bhat R; Noskov SY; Tyrrell DL; Tuszynski JA; Houghton M
Toxicol Lett; 2014 Nov; 230(3):382-92. PubMed ID: 25127758
[TBL] [Abstract][Full Text] [Related]
3. The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping.
Witchel HJ; Dempsey CE; Sessions RB; Perry M; Milnes JT; Hancox JC; Mitcheson JS
Mol Pharmacol; 2004 Nov; 66(5):1201-12. PubMed ID: 15308760
[TBL] [Abstract][Full Text] [Related]
4. Deposition of pentamidine analogues in the human body - spectroscopic and computational approaches.
Żołek T; Dömötör O; Rezler M; Enyedy ÉA; Maciejewska D
Eur J Pharm Sci; 2021 Jun; 161():105779. PubMed ID: 33667666
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of HERG channel block.
Kamiya K; Niwa R; Mitcheson JS; Sanguinetti MC
Mol Pharmacol; 2006 May; 69(5):1709-16. PubMed ID: 16474003
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin.
Alexandrou AJ; Duncan RS; Sullivan A; Hancox JC; Leishman DJ; Witchel HJ; Leaney JL
Br J Pharmacol; 2006 Apr; 147(8):905-16. PubMed ID: 16474415
[TBL] [Abstract][Full Text] [Related]
7. Effect of terfenadine and pentamidine on the HERG channel and its intracellular trafficking: combined analysis with automated voltage clamp and confocal microscopy.
Tanaka H; Takahashi Y; Hamaguchi S; Iida-Tanaka N; Oka T; Nishio M; Ohtsuki A; Namekata I
Biol Pharm Bull; 2014; 37(11):1826-30. PubMed ID: 25366487
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological evaluation of pentamidine and 17-AAG in human stem cell-derived cardiomyocytes for safety assessment.
Asahi Y; Nomura F; Abe Y; Doi M; Sakakura T; Takasuna K; Yasuda K
Eur J Pharmacol; 2019 Jan; 842():221-230. PubMed ID: 30391349
[TBL] [Abstract][Full Text] [Related]
9. In vitro screening of pentamidine analogs against bacterial and fungal strains.
Maciejewska D; Żabiński J; Kaźmierczak P; Wójciuk K; Kruszewski M; Kruszewska H
Bioorg Med Chem Lett; 2014 Jul; 24(13):2918-23. PubMed ID: 24830598
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects and mechanism of dihydroberberine on hERG channels expressed in HEK293 cells.
Yu D; Lv L; Fang L; Zhang B; Wang J; Zhan G; Zhao L; Zhao X; Li B
PLoS One; 2017; 12(8):e0181823. PubMed ID: 28763460
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking and molecular dynamics studies on the structure-activity relationship of fluoroquinolone for the HERG channel.
Luo F; Gu J; Chen L; Xu X
Mol Biosyst; 2014 Nov; 10(11):2863-9. PubMed ID: 25100024
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of pentamidine-induced hERG trafficking inhibition.
Dennis AT; Wang L; Wan H; Nassal D; Deschenes I; Ficker E
Mol Pharmacol; 2012 Feb; 81(2):198-209. PubMed ID: 22046004
[TBL] [Abstract][Full Text] [Related]
13. Pentamidine-induced long QT syndrome and block of hERG trafficking.
Kuryshev YA; Ficker E; Wang L; Hawryluk P; Dennis AT; Wible BA; Brown AM; Kang J; Chen XL; Sawamura K; Reynolds W; Rampe D
J Pharmacol Exp Ther; 2005 Jan; 312(1):316-23. PubMed ID: 15340016
[TBL] [Abstract][Full Text] [Related]
14. Fluorescently labeled analogues of dofetilide as high-affinity fluorescence polarization ligands for the human ether-a-go-go-related gene (hERG) channel.
Singleton DH; Boyd H; Steidl-Nichols JV; Deacon M; Groot MJ; Price D; Nettleton DO; Wallace NK; Troutman MD; Williams C; Boyd JG
J Med Chem; 2007 Jun; 50(13):2931-41. PubMed ID: 17536794
[TBL] [Abstract][Full Text] [Related]
15. Propofol inhibits hERG K
Han SN; Jing Y; Yang LL; Zhang Z; Zhang LR
Eur J Pharmacol; 2016 Nov; 791():168-178. PubMed ID: 27575519
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical basis for binding and voltage-dependent block of hERG channels by structurally diverse drugs.
Sanguinetti MC; Chen J; Fernandez D; Kamiya K; Mitcheson J; Sanchez-Chapula JA
Novartis Found Symp; 2005; 266():159-66; discussion 166-70. PubMed ID: 16050267
[TBL] [Abstract][Full Text] [Related]
17. Structural determinants of HERG channel block by clofilium and ibutilide.
Perry M; de Groot MJ; Helliwell R; Leishman D; Tristani-Firouzi M; Sanguinetti MC; Mitcheson J
Mol Pharmacol; 2004 Aug; 66(2):240-9. PubMed ID: 15266014
[TBL] [Abstract][Full Text] [Related]
18. TSSF-hERG: A machine-learning-based hERG potassium channel-specific scoring function for chemical cardiotoxicity prediction.
Meng J; Zhang L; Wang L; Li S; Xie D; Zhang Y; Liu H
Toxicology; 2021 Dec; 464():153018. PubMed ID: 34757159
[TBL] [Abstract][Full Text] [Related]
19. Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.
Xia M; Shahane SA; Huang R; Titus SA; Shum E; Zhao Y; Southall N; Zheng W; Witt KL; Tice RR; Austin CP
Toxicol Appl Pharmacol; 2011 May; 252(3):250-8. PubMed ID: 21362439
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine.
Gualdani R; Tadini-Buoninsegni F; Roselli M; Defrenza I; Contino M; Colabufo NA; Lentini G
Pharmacol Res Perspect; 2015 Oct; 3(5):e00160. PubMed ID: 26516576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
